Диссертация (792450), страница 57
Текст из файла (страница 57)
М., 2003.- 470 с.213.ШахгильдянИ.В.Эпидемиологическаяхарактеристикаипрофилактика парентеральных вирусных гепатитов // Практическаягепатология / Под ред. Н.А. Мухина. М., 2004. С. 18–26.214.Энтин Г.М. Лечение алкоголизма и организация наркологическойпомощи М.: Прогресс, 1979.- 289 с.215.Юлдашев В.Л. Формирование наркоманий и токсикоманий удевочек подростков: Автореф. дис. … докт. мед.
наук. Уфа, 1996. – 46 с.216.Ющук Н.Д., Венгеров Ю.Я. Лекции по инфекционным болезням.М.: Медицина, 2007. – 1025 с.217.Ялтонский В.М. Теоретическая модель мотивации к лечениюзависимости от психоактивных веществ // Вопросы наркологии. 2009.№ 6. С. 68–76.218.Ялтонский В.М., Сирота Н.А. Мотивационная терапия //Наркология. 2003. № 4. С. 41–44.219.Ялтонскийповедения:В.М.,развитие,СиротаН.А.достижения,Психологияпроблемыисовладающегоперспективы//Совладающее поведение: Современное состояние и перспективы / Под.ред. А.Л. Журавлева, Т.Л. Крюковой, Е.А. Сергиенко.
М.: Изд-во«Институт психологии РАН», 2008. С. 21–54.220.Ялтонский В.М., Сирота Н.А., Ялтонская А.В. Стигматизация,дискриминация и раскрытие диагноза зависимости от наркотиков иалкоголя, позитивного статуса ВИЧ-инфицирования как проблема368третичной профилактики // Руководство по наркологии / Под ред. Н.Н.Иванца. 2-е изд. М.: ООО «Медицинское информационное агентство»,2008. С. 795–800.221.Ялтонский В.М., Колпаков Я.В., Ромащенко Г.И. Ценностно-смысловые и эмоциональные предикторы мотивации на лечение лиц,зависимых от алкоголя // Вопросы наркологии. 2009.
№ 6. С. 70–77.222.ЯськоБ.А. Врач, психология личности - Краснодар: Изд-воКубГУ, 2001. - 248 с.223.Abdala N., Stephens P.C., Griffith B.P., Heimer R. Survival of HIV-Iin syringes. // Jornal of AIDS and Human Retrovirology. 1999. Vol. 20(1). P.73–80.224.Akahane Y., Kojima M., Sugai Y. et al. Hepatitis C virus infection inspouses of patients with type C chronic liver disease // Annals of InternalMedicine. 1994. Vol. 120.
P. 748–752.225.Alberti A. Interferon therapy of acute hepatitis C // Journal of ViralHepatitis. 1995. Vol. 1. P. 37–45.226.Alberti A., Morisca G., Chemello L. et al. Hepatitis C viraemia andliver disease in symptom-free individuals with anti-HCV // Lancet. 1992.Vol. 340. P. 697–698.227.Arif M., Al-Swayeh M., Al-Faleh F.Z., Ramia S. Risk of hepatitis Cvirus infection among household contacts of Saudi patients with chronic liverdisease // Journal of Viral Hepatitis. 1996. Vol.
3. P. 97–101.228.Ball J.С., Lange W.R., Myers C.P. Reducing the risk of AIDS throughmethadone maintenance treatment // Journal of Health and Social Behavior.1998. Vol. 29. P. 214–226.229.Bandura A. Social foundation of thought and action. A socialcognitive theory. Englewood Cliffs, NJ: Prentice-Hall, 1986.230.Bandura A. Social cognitive theory of self-regulation // OrganizationalBehavior and Human Decision Processes. 1991. № 50.
Р. 248–287.369231.Bandura A. Self-efficacy: The exercise of control. New York: W.H.Freeman, 1997.- 604 p.232.Bandura A. Social cognitive theory: An agentic perspective // AnnualReview of Psychology. 2001. № 52. Р. 1–26.233.Bates M.E., Lobovie E.W., White H.R. The effect of sensationseeking needs on alcohol and marijuana use in adolescence // Bulletin ofSociety of Psychologists in Addictive Behaviours. 1986. Vol. 5.
№ 1. P. 29–36.234.Bauman P.S., Levine S.A. The Development of Children of Drugaddicts // International Journal of Mental Health and Addiction. 1986. Vol.21. P. 849–863.235.Beck A.T. Cognitive therapy and emotion disorders. New York:International Universities press, 1967.- 308 c.236.Bennet G., Vourakis C., Wooif D. Sudstance Abuse – Pharmacologic,Developmental and Clinical Perspectives. New York: Wiley MedicalPudlications, 1983.- 246 c.237.Blatt S.J., Berman W. Psychological assessment of psychopathologyin opiate addicts // Journal of Nervous and Mental Disease. 1984. Vol. 3. P.156–165.238.Engel G.
The need for a new medical model: A challenge forbiomedicine // Science. 1977. № 196. P. 129–136.239.Borrell-Garrio Fr., Suchman A.L., Epstein R.M. The BiopsychosocialModel 25 Years Later: Principles, Practice, and Scientific Inquiry // Annalsof Family Medicine. 2004. Vol.
2. № 6. P. 576–582.240.Bouter L.M., Knipshild P.G., Feij,J.A, Volovies,A. Sensationseeking and injury risk in downhill skiing // Personality and IndividualDifferences. 1988. Vol. 9. № 3. P. 667–673.241.Brechot Ch. Hepatitis C virus. Molecular biology and geneticvariability // Digestive Diseases and Sciences 1996. Vol. 41. P. 6S–21S.370242.Brechot Ch., Kremsdorf D.
Genetic variation of the hepatitis C virus(HCV) genome: randome events or a clinically relevant issue? // Hepatol.1993. Vol. 17. P. 265–268.243.Bresters D., Mauser-Bunschoten E.P., Reesink H.W. et al. Sexualtransmission of hepatitis C virus // Lancet. 1993. Vol. 342. P. 210–211.244.Brillanti S., Foli M., Gaiani S. et al. Persistent hepatitis C viraemiawithout liver disease // Lancet. 1993. Vol. 341.
P. 464–465.245.Brook J.C., Whiteman M., Finch S., et al. Young adult drug use anddelinquency: childhood antecedents and adolescent mediators // Journal ofthe American Academy of Child and Adolescent Psychiatry. 1996. Vol.35(12). P. 1584–1592.246.Campbell B.K., Stark M.J. Psychopathology and personalitycharacteristics in different form of substance abuse // International Journal ofMental Health and Addiction. 1990. Vol. 25.
№ 2. P. 1467–1474.247.Catalano R.F. et al. An experimental intervention with families ofsubstance abusers: one year follow up of the focus on families project //Addiction. 1999. Vol. 94 (2). P. 251–255.248.Chung R.T., Kim A.Y., Polsky B. HIV/ Hepatitis B and C co-infection: pathogenic interactions, natural history and therapy // AntiviralChemistry & Chemotherapy. 2001. Vol.
12. Supplement 1. P. 73–91.249.Clark A. The Identification and modification of defense mechanism incounseling // Journal of Counseling and Development. 1991. Vol. 69. P. 231–236.250.Clark, David A., Aaron T. Beck, and Brad A. Alford, ScientificFoundations of Cognitive Theory and Therapy of Depression, New York:John Wiley, 1999.- 494 p.251.Clarke S., Keenan E., Ryan M., Barry M., Mulcahy F. DirectlyObserved Antiretroviral Therapy for Injection Drug Users With HIVInfection // The AIDS reader. 2002. Vol.
12. № 7. P. 305–316.371252.Conte D., Fraquelli M., Prati D. et al. Prevalence and clinical courseof chronic hepatitis C virus (HCV) infection and rate of HCV verticaltransmission in a cohort of 15250 pregnant women // Hepatology. 2000. Vol.31. P. 751–755.253.Daugherty R.P., Laukefeld C. Reducing the risk for substance abuse:A life span approach.
New York; London: Plenium Press, 1998. – 178 p.254.Deaux K., Major B. A social-psyhological model of gender //Theoretical Perspectives on sexual Differences. New York, London: YaleUniversity Press, 1990. P. 89–99.255.Desmet V.G., Gerber M., Hoofnagle J.H. et al. Classification ofchronic hepatitis: diagnosis, grading and staging // Hepatology. 1994. Vol.19. P. 1513–1519.256.Dorus W., Seney E.C. Depression, demographic dimensions and drugabuse // The American Journal of Psychology. 1980.
Vol. 137. P. 699–704.257.Dusheiko G., Schmilovitz-Weiss H., Brown D. et al. Hepatitis C virusgenotypes: an investigation of type – specific differences in geographicorigin and disease // Hepatology. 1994. Vol. 19. P. 13–18.258.Dyke Van D., Heaslip J., Hogenson D., Vedders L. Young people anddrugs: evaluation and treatment // Hazelden. 1989. – 144 p.259.Easthope G. Perceptions of cassias of drug use series of articles ininternational journal of the addictions // Journal of Mental Health andAddiction.
1993. Vol. 28 (6). P. 559–569.260.Ellis A. The road to tolerance: the philosophy of rational emotivebehavior therapy. New York: Prometheus Books, 2004. – 272 p.261.Engel G. The need for a new medical model: A challenge forbiomedicine // Science. 1977. № 196. P. 129–136.262.Estrada P. Adolescents self-report of prosocial responses to friend andacquaintance: Therole of sympathy-related cognitive, affective andmotivational processes // Journal of Research on Adolescence. 1995. Vol. 5.P. 173–200.372263.Farci P., Alter H.J., Govindarajan S. et al. Lack of protectiveimmunity against reinfectionwith hepatitis C virus // Science.
1992. Vol.258. P. 135–140.264.Fergusson R.W. Drug abuse control. Boston: Holbrook Press, 1975. –470 p.265.Finnegan L. Perinatal morbidity and mortality in substance usingfamilies: effects and intervention strategies // Bulletin on Narcotics. 1994.Vol.
46. № 1. P. 19–43.266.Folkman S. Personal Control and Stress and Coping processes: atheoretical Analysis // Journal of Personality and Social Psychology. 1984.Vol. 46. № 4. P. 839–852.267.George F.R,. Goldberg S.R. Genetic approaches to the analysis ofaddiction process // Trends in Pharmacological Sciences. 1989. Vol. 10.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
